Blair William & CO Viking Therapeutics, Inc. Transaction History

Blair William & CO

$31.4 Billion
Q1 2024

A detailed history of Blair William & CO transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Blair William & CO holds 299,235 shares of VKTX stock, worth $15.1 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

299,235

Previous 58,372 412.63%

Holding current value

$15.1 Million

Previous $1.09 Million 2159.39%

% of portfolio

0.08%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$17.4 - $94.5 $4.19 Million - $22.8 Million	240,863 Added 412.63%	299,235 $24.5 Million
Q4 2023 Feb 12, 2024	SELL	$9.24 - $19.64 $297,278 - $631,877	-32,173 Reduced 35.53%	58,372 $1.09 Million
Q3 2023 Nov 09, 2023	SELL	$10.92 - $16.0 $287,567 - $421,344	-26,334 Reduced 22.53%	90,545 $1 Million
Q2 2023 Aug 11, 2023	BUY	$14.84 - $24.79 $132,580 - $221,473	8,934 Added 8.28%	116,879 $1.89 Million
Q1 2023 May 12, 2023	BUY	$8.08 - $17.33 $604,287 - $1.3 Million	74,788 Added 225.56%	107,945 $1.8 Million

Q4 2022 Feb 10, 2023	SELL	$2.72 - $9.4 $219,316 - $757,931	-80,631 Reduced 70.86%	33,157 $311,000
Q3 2022 Nov 09, 2022	SELL	$2.55 - $3.89 $115,081 - $175,555	-45,130 Reduced 28.4%	113,788 $310,000
Q2 2022 Aug 10, 2022	SELL	$2.11 - $3.15 $1,685 - $2,516	-799 Reduced 0.5%	158,918 $459,000
Q1 2022 May 13, 2022	BUY	$3.0 - $4.88 $19,362 - $31,495	6,454 Added 4.21%	159,717 $479,000
Q4 2021 Feb 14, 2022	BUY	$4.6 - $6.72 $37,177 - $54,311	8,082 Added 5.57%	153,263 $705,000
Q3 2021 Nov 12, 2021	SELL	$5.58 - $7.04 $64,476 - $81,347	-11,555 Reduced 7.37%	145,181 $912,000
Q2 2021 Aug 12, 2021	BUY	$5.19 - $6.73 $15,570 - $20,190	3,000 Added 1.95%	156,736 $939,000
Q1 2021 May 13, 2021	BUY	$5.74 - $9.67 $39,663 - $66,819	6,910 Added 4.71%	153,736 $972,000
Q4 2020 Feb 09, 2021	BUY	$5.3 - $6.71 $198,352 - $251,121	37,425 Added 34.21%	146,826 $827,000
Q3 2020 Nov 06, 2020	BUY	$5.73 - $8.11 $208,199 - $294,676	36,335 Added 49.73%	109,401 $637,000
Q2 2020 Aug 12, 2020	SELL	$4.35 - $8.08 $6,524 - $12,120	-1,500 Reduced 2.01%	73,066 $527,000
Q1 2020 May 11, 2020	SELL	$3.45 - $7.95 $52,629 - $121,277	-15,255 Reduced 16.98%	74,566 $349,000
Q4 2019 Feb 13, 2020	SELL	$6.38 - $8.73 $385,907 - $528,051	-60,487 Reduced 40.24%	89,821 $720,000
Q3 2019 Nov 12, 2019	SELL	$6.55 - $8.6 $53,382 - $70,090	-8,150 Reduced 5.14%	150,308 $1.03 Million
Q2 2019 Aug 13, 2019	SELL	$7.67 - $10.63 $37,007 - $51,289	-4,825 Reduced 2.95%	158,458 $1.32 Million
Q1 2019 May 14, 2019	BUY	$7.58 - $9.94 $11,013 - $14,442	1,453 Added 0.9%	163,283 $1.62 Million
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $1.12 Million - $2.53 Million	156,330 Added 2842.36%	161,830 $1.24 Million
Q3 2018 Nov 13, 2018	BUY	$9.7 - $19.65 $4,850 - $9,825	500 Added 10.0%	5,500 $96,000
Q2 2018 Aug 13, 2018	BUY	$3.88 - $12.74 $19,400 - $63,700	5,000 New	5,000 $47,000

Others Institutions Holding VKTX

# of Institutions

426

Shares Held

63.1M

Call Options Held

7.39M

Put Options Held

5.13M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.87B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account